Pharmacist-led interventions to reduce drug-related problems in prescribing for Vietnamese outpatients

Q4 Pharmacology, Toxicology and Pharmaceutics Pharmaceutical Sciences Asia Pub Date : 2022-01-01 DOI:10.29090/psa.2022.01.21.096
N. Nguyen, Thang Nguyen, S. T. Pham, T. H. Nguyen
{"title":"Pharmacist-led interventions to reduce drug-related problems in prescribing for Vietnamese outpatients","authors":"N. Nguyen, Thang Nguyen, S. T. Pham, T. H. Nguyen","doi":"10.29090/psa.2022.01.21.096","DOIUrl":null,"url":null,"abstract":"Inappropriate prescribing reduces the quality of treatment and leads to a waste of resources. The World Health Organization estimates that more than half of all drugs are prescribed, dispensed, or sold inappropriately, and that half of all patients do not take them correctly. Drug-related problems can increase the risk of side effects, drug interactions, antimicrobial resistance, increase costs for treatment (in terms of both direct medication costs and indirect medication costs), and pressure the insurance budget society. According to the studies, about 50% to 80% of drug-related problems may be preventable. In particular, clinical pharmacists help identify, treat and have a crucial role in preventing drug-related problems through specific interventions. The pharmacist's contribution to improving the quality of medication use and patient safety can be assessed directly or indirectly by determining the number of drug-related problems being managed/prevented or by cost-effective treatment. All over the world, many studies are showing the critical role of pharmacists in identifying and managing drug-related problems in prescribing. In Sweden, pharmacists' recommendations on DRPs might positively influence physicians’ prescribing quality and contribute to better and safer drug therapy for patients. In addition, Japanese pharmacists also had an essential role in providing medication safety, with potential cost savings.","PeriodicalId":19761,"journal":{"name":"Pharmaceutical Sciences Asia","volume":"8 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Sciences Asia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29090/psa.2022.01.21.096","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Inappropriate prescribing reduces the quality of treatment and leads to a waste of resources. The World Health Organization estimates that more than half of all drugs are prescribed, dispensed, or sold inappropriately, and that half of all patients do not take them correctly. Drug-related problems can increase the risk of side effects, drug interactions, antimicrobial resistance, increase costs for treatment (in terms of both direct medication costs and indirect medication costs), and pressure the insurance budget society. According to the studies, about 50% to 80% of drug-related problems may be preventable. In particular, clinical pharmacists help identify, treat and have a crucial role in preventing drug-related problems through specific interventions. The pharmacist's contribution to improving the quality of medication use and patient safety can be assessed directly or indirectly by determining the number of drug-related problems being managed/prevented or by cost-effective treatment. All over the world, many studies are showing the critical role of pharmacists in identifying and managing drug-related problems in prescribing. In Sweden, pharmacists' recommendations on DRPs might positively influence physicians’ prescribing quality and contribute to better and safer drug therapy for patients. In addition, Japanese pharmacists also had an essential role in providing medication safety, with potential cost savings.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
药剂师主导的干预措施,以减少越南门诊病人在开处方时出现的药物相关问题
不适当的处方降低了治疗质量并导致资源浪费。世界卫生组织估计,所有药物中有一半以上的处方、配药或销售不当,一半的患者没有正确服用。药物相关问题可增加副作用、药物相互作用、抗菌素耐药性的风险,增加治疗费用(包括直接用药费用和间接用药费用),并给社会的保险预算带来压力。根据这些研究,大约50%到80%与毒品有关的问题是可以预防的。特别是,临床药师通过具体的干预措施帮助识别、治疗并在预防药物相关问题方面发挥关键作用。药剂师对提高药物使用质量和患者安全的贡献可以通过确定正在管理/预防的药物相关问题的数量或通过具有成本效益的治疗来直接或间接地评估。在世界各地,许多研究表明药剂师在确定和管理处方中与药物有关的问题方面发挥着关键作用。在瑞典,药剂师对DRPs的建议可能会对医生的处方质量产生积极影响,并有助于为患者提供更好、更安全的药物治疗。此外,日本药剂师在提供药物安全方面也发挥了重要作用,有可能节省成本。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Pharmaceutical Sciences Asia
Pharmaceutical Sciences Asia Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
0.90
自引率
0.00%
发文量
59
期刊介绍: The Pharmaceutical Sciences Asia (PSA) journal is a double-blinded peer-reviewed journal in English published quarterly, by the Faculty of Pharmacy, Mahidol University, Thailand. The PSA journal is formerly known as Mahidol University Journal of Pharmaceutical Sciences and committed to the timely publication of innovative articles and reviews. This journal is available in both printed and electronic formats. The PSA journal aims at establishing a publishing house that is open to all. It aims to disseminate knowledge; provide a learned reference in the field; and establish channels of communication between academic and research expert, policy makers and executives in industry and investment institutions. The journal publishes research articles, review articles, and scientific commentaries on all aspects of the pharmaceutical sciences and multidisciplinary field in health professions and medicine. More specifically, the journal publishes research on all areas of pharmaceutical sciences and related disciplines: Clinical Pharmacy Drug Synthesis and Discovery Targeted-Drug Delivery Pharmaceutics Biopharmaceutical Sciences Phytopharmaceutical Sciences Pharmacology and Toxicology Pharmaceutical Chemistry Nutraceuticals and Functional Foods Natural Products Social, Economic, and Administrative Pharmacy Clinical Drug Evaluation and Drug Policy Making Antimicrobials, Resistance and Infection Control Pharmacokinetics and Pharmacodynamics.
期刊最新文献
Locally-isolated protease-producing Bacillus spp. from soil inhibits biofilm formation of Staphylococcus aureus Medication errors analysis in Asia and Australia: A systematic review The effect of different sweeteners on the free radical scavenging activities, alcohol contents, sugar reductions, and hedonic properties of green tea kombucha Development and validation of a GC-MS method for determination of amphetamine-type stimulants and ketamine in human hair Effect of zonisamide and Nigella sativa on blood-brain barrier permeability and neurological severity in traumatic brain injury-induced mice
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1